Nanobody-displaying porous silicon nanoparticles for the co-delivery of siRNA and doxorubicin-Reference-Cited by-同舟云学术

Nanobody-displaying porous silicon nanoparticles for the co-delivery of siRNA and doxorubicin

Published:2021 Issue:1 Volume:9 Page:133-147
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Tieu Terence¹²³⁴⁵,Wojnilowicz Marcin⁵⁶⁴,Huda Pie⁷⁸⁹¹⁰¹¹,Thurecht Kristofer J.⁷⁸⁹¹⁰¹¹^ORCID,Thissen Helmut⁵⁶⁴^ORCID,Voelcker Nicolas H.¹²³⁴⁵^ORCID,Cifuentes-Rius Anna¹²³⁴^ORCID

Affiliation:

1. Monash Institute of Pharmaceutical Sciences

2. Monash University

3. Parkville

4. Australia

5. Commonwealth Scientific and Industrial Research Organisation (CSIRO) Manufacturing

6. Clayton

7. Centre for Advanced Imaging

8. Australian Institute for Bioengineering and Nanotechnology (AIBN)

9. ARC Centre of Excellence in Convergent Bio-Nano Science and Technology and ARC Training Centre for Innovation in Biomedical Imaging Technology

10. University of Queensland

11. Brisbane

Abstract

Targeted delivery of chemotherapeutics to cancer cells has the potential to yield high drug concentrations in cancer cells while minimizing any unwanted side effects.

Funder

Commonwealth Scientific and Industrial Research Organisation

Carlsbergfondet

National Health and Medical Research Council

Australian Research Council

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering

Link

http://pubs.rsc.org/en/content/articlepdf/2021/BM/D0BM01335H

Reference60 articles.